Glycine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
251 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Multiple myeloma | D009101 | — | C90.0 | 9 | 16 | 3 | 1 | — | 23 |
| Plasma cell neoplasms | D054219 | — | — | 9 | 16 | 3 | 1 | — | 23 |
| Anemia | D000740 | HP_0001903 | D64.9 | 6 | 3 | 3 | 4 | 2 | 18 |
| Syndrome | D013577 | — | — | 2 | 3 | 3 | 1 | — | 8 |
| Diarrhea | D003967 | HP_0002014 | R19.7 | 2 | 2 | 4 | 2 | — | 8 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | 3 | 1 | 1 | — | 5 |
| Iron-deficiency anemia | D018798 | HP_0001891 | D50 | — | — | 2 | 2 | 1 | 5 |
| Iron deficiencies | D000090463 | — | — | — | — | 2 | 2 | 1 | 5 |
| Chronic renal insufficiency | D051436 | — | N18 | — | 2 | 1 | 1 | — | 4 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | 1 | 1 | 1 | 4 |
Show 23 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Schizophrenia | D012559 | EFO_0000692 | F20 | 4 | 10 | 3 | — | 3 | 18 |
| Healthy volunteers/patients | — | — | — | 9 | 1 | 1 | — | 2 | 12 |
| Leukemia | D007938 | — | C95 | 3 | 3 | 1 | — | — | 6 |
| Psychotic disorders | D011618 | — | F20.81 | 1 | 3 | 1 | — | 2 | 6 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | 4 | — | 2 | 6 |
| Myelodysplastic syndromes | D009190 | — | D46 | 2 | 3 | 1 | — | — | 5 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 3 | 2 | 1 | — | — | 5 |
| Myeloid leukemia | D007951 | — | C92 | 3 | 2 | 1 | — | — | 5 |
| Preleukemia | D011289 | — | — | 2 | 3 | 1 | — | — | 5 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 3 | 2 | — | 2 | 5 |
Show 26 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 7 | 2 | — | — | 1 | 8 |
| Covid-19 | D000086382 | — | — | 2 | 5 | — | — | 1 | 8 |
| Carcinoma | D002277 | — | C80.0 | 4 | 5 | — | — | — | 5 |
| Lymphoma | D008223 | — | C85.9 | 3 | 4 | — | — | — | 5 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 4 | 1 | — | — | — | 4 |
| Mental disorders | D001523 | EFO_0000677 | F91.9 | — | 1 | — | — | 3 | 4 |
| Amyloidosis | D000686 | EFO_1001875 | E85 | 3 | 1 | — | — | — | 3 |
| Recurrence | D012008 | — | — | 2 | 3 | — | — | — | 3 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 2 | — | — | 1 | 3 |
| Mantle-cell lymphoma | D020522 | — | — | 1 | 3 | — | — | — | 3 |
Show 109 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Aging | D000375 | GO_0007568 | R41.81 | 2 | — | — | — | 1 | 3 |
| Immunoglobulin light-chain amyloidosis | D000075363 | — | — | 2 | — | — | — | — | 2 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | 1 | 2 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | 1 | — | — | — | 1 | 2 |
| Poems syndrome | D016878 | EFO_1001115 | — | 1 | — | — | — | — | 1 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | — | 1 |
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | — | — | — | — | 1 |
| Muscle weakness | D018908 | HP_0001324 | — | 1 | — | — | — | — | 1 |
| Pulmonary fibrosis | D011658 | — | — | 1 | — | — | — | — | 1 |
| Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sciatica | D012585 | HP_0011868 | M54.3 | — | — | — | — | 4 | 4 |
| Intervertebral disc displacement | D007405 | EFO_1001800 | — | — | — | — | — | 4 | 4 |
| Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | — | — | — | — | 3 | 3 |
| Oxidative stress | D018384 | EFO_1001905 | — | — | — | — | — | 3 | 3 |
| Dental plaque | D003773 | — | — | — | — | — | — | 3 | 3 |
| Morbid obesity | D009767 | EFO_0001074 | — | — | — | — | — | 2 | 2 |
| Newborn respiratory distress syndrome | D012127 | — | P22 | — | — | — | — | 2 | 2 |
| Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | — | — | — | — | 2 | 2 |
| Transurethral resection of prostate | D020728 | — | — | — | — | — | — | 2 | 2 |
| Hyperplasia | D006965 | EFO_0000536 | — | — | — | — | — | 2 | 2 |
Show 76 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,017 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use